Report #2838197

Received Apr 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: ID
Recovered: Unknown
Vaccinated: —
Onset: Mar 28, 2025
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HIBV	HIB (PEDVAXHIB)	MERCK & CO. INC.	UNK	X022981	OT

Symptoms (1)

Product storage error

Symptom narrative

Caller reported PEDVAX HIB was administered after a temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-Mar-2025, the patient started therapy with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) Injection (0.5ML, lot #X022981, expiration date: 21-May-2026, strength unknown), administered by Intramuscular route for the treatment of Prophylaxis after a temperature excursion (Product storage error). Operator Of Device: Health Professional Administered dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) experienced the temperature excursion below 54.19 Fahrenheit degrees (F) for 2 hours 45 minutes. No previous temperature excursions. No other information provided. No product quality complaints reported. This is one of five reports from the same reporter.